Patents Assigned to Prodigene
-
Patent number: 8685405Abstract: Plants are produced that express an amino acid sequence that, when administered to a fish, produce an antigenic or immune response in the fish. The amino acid sequence in one embodiment is an antigen from an organism that causes pathology in fish. The plant tissue may be fed to the fish, or mixed with other materials and fed to fish, or extracted and administered to the fish.Type: GrantFiled: March 14, 2012Date of Patent: April 1, 2014Assignees: ProdiGene, Inc., Novartis AGInventors: Linda Bootland, Katherine Beifuss
-
Patent number: 8158855Abstract: Plants are produced that express an amino acid sequence that, when administered to a fish, produce an antigenic or immune response in the fish. The amino acid sequence in one embodiment is an antigen from an organism that causes pathology in fish. The plant tissue may be fed to the fish, or mixed with other materials and fed to fish, or extracted and administered to the fish.Type: GrantFiled: November 15, 2007Date of Patent: April 17, 2012Assignees: ProdiGene, Inc., Novartis A.G.Inventors: Linda Bootland, Katherine Beifuss
-
Patent number: 7985891Abstract: Plants are produced that express an amino acid sequence that, when administered to a fish, produce an antigenic or immune response in the fish. The amino acid sequence in one embodiment is an antigen from an organism that causes pathology in fish. The plant tissue may be fed to the fish, or mixed with other materials and fed to fish, or extracted and administered to the fish.Type: GrantFiled: November 15, 2007Date of Patent: July 26, 2011Assignees: ProdiGene, Inc., Novartis AGInventors: Linda Bootland, Katherine Beifuss
-
Publication number: 20090280136Abstract: Plants are produced that express an amino acid sequence that, when administered to a fish, produce an antigenic or immune response in the fish. The amino acid sequence in one embodiment is an antigen from an organism that causes pathology in fish. The plant tissue may be fed to the fish, or mixed with other materials and fed to fish, or extracted and administered to the fish.Type: ApplicationFiled: November 15, 2007Publication date: November 12, 2009Applicants: ProdiGene, Inc., Novartis AGInventors: Linda Bootland, Katherine Beifuss
-
Publication number: 20090249519Abstract: Plants are produced that express an amino acid sequence that, when administered to a fish, produce an antigenic or immune response in the fish. The amino acid sequence in one embodiment is an antigen from an organism that causes pathology in fish. The plant tissue may be fed to the fish, or mixed with other materials and fed to fish, or extracted and administered to the fish.Type: ApplicationFiled: November 15, 2007Publication date: October 1, 2009Applicants: ProdiGene, Inc., Novartis AGInventors: Linda Bootland, Katherine Beifuss
-
Patent number: 7541515Abstract: Increased expression of heterologous proteins in a plant is achieved by introducing the nucleotide sequence encoding the heterologous protein into a plant that has high oil seed content compared to low oil seed and/or is introduced into a plant having reduced alcohol soluble proteins in the endosperm. The nucleotide sequence may be introduced by direct transformation into the plant, or by direct transformation into another plant, and crossing with the high oil plant or plant have reduced levels of alcohol soluble protein in the endosperm. Further, the nucleotide sequences may be introduced into one or both of the high oil plant and the plant having reduced levels of alcohol soluble proteins, and the plants may be crossed to result in a progeny having even further increased expression levels of the heterologous protein.Type: GrantFiled: September 23, 2002Date of Patent: June 2, 2009Assignee: ProdiGene, Inc.Inventors: Elizabeth Hood, John Howard, Donna Delaney
-
Patent number: 7504560Abstract: The anti-viral vaccine of the present invention is produced in transgenic plants and then administered through standard vaccine introduction method or through the consumption of the edible portion of those plants. A DNA sequence encoding for the expression of a surface antigen of a viral pathogen is isolated and ligated to a promoter which can regulate the production of the surface antigen in a transgenic plant. This gene is then transferred to plant cells using a procedure that results in its integration into the plant genome, such as through the use of an Agrobacterium tumenfaciens plasmid vector system. Preferably, the foreign gene is expressed in an portion of the plant that is edible by humans or animals. In a preferred procedure, the vaccine is administered through the consumption of the edible plant as food, preferably in the form of a fruit or vegetable juice which can be taken orally.Type: GrantFiled: May 12, 2005Date of Patent: March 17, 2009Assignee: Prodigene, Inc.Inventors: Charles Joel Arntzen, Dominic Man-Kit Lam
-
Patent number: 7393998Abstract: Plants are engineered to express proinsulin or insulin. The plants can be used as a source of the protein for a variety of purposes. Plant tissue can be orally administered to animals to replace the necessity of injection of insulin. Alternatively, the protein can be extracted from plant tissue and delivered to animals. Plant produced proteins can also provide a less expensive and more readily available source of the protein as reagents or in other experimentation involving insulin proteins.Type: GrantFiled: March 7, 2003Date of Patent: July 1, 2008Assignee: ProdiGene, Inc.Inventors: Stephen Streatfiled, John Howard
-
Publication number: 20060015971Abstract: Production of proteases in plants is set forth, whereby heterologous DNA encoding the protease is introduced into the plant and expression of the protein achieved. By such methods, expression is achieved in plants wherein the plant cell is not damaged, the protein can be recovered without contamination by other proteases, and can be expressed at levels such that commercial production of the enzyme is obtained. Expression levels can be at 0.1% of total soluble protein of the plant, or higher.Type: ApplicationFiled: September 14, 2005Publication date: January 19, 2006Applicant: ProdiGene, Inc.Inventors: John Howard, Elizabeth Hood
-
Publication number: 20040250298Abstract: The present invention provides novel methods for determining whether a cell has incorporated a polynucleotide comprising the use of organophosphate hydrolase activity as a marker which has both selectable and screenable properties.Type: ApplicationFiled: December 3, 2003Publication date: December 9, 2004Applicant: ProdiGene, Inc.Inventors: T. Scott Pinkerton, John A. Howard, James R. Wild
-
Patent number: 6800792Abstract: Expression of laccase in plants at commercial levels of production is provided. The laccase gene is preferably operably linked with promoter sequences preferentially directing expression of laccase to the seed of the plant, and may additionally include sequences directing expression to the plant cell wall. Methods of improving the process of introducing DNA into plants via Agrobacterium are also provided.Type: GrantFiled: March 12, 2001Date of Patent: October 5, 2004Assignees: ProdiGene Inc., Genencor International, Inc.Inventors: John A. Howard, Elizabeth Hood, Joseph Jilka
-
Publication number: 20030200566Abstract: Plants are engineered to express proinsulin or insulin. The plants can be used as a source of the protein for a variety of purposes. Plant tissue can be orally administered to animals to replace the necessity of injection of insulin. Alternatively, the protein can be extracted from plant tissue and delivered to animals. Plant produced proteins can also provide a less expensive and more readily available source of the protein as reagents or in other experimentation involving insulin proteins.Type: ApplicationFiled: March 7, 2003Publication date: October 23, 2003Applicant: ProdiGene, Inc.Inventors: Stephen Streatfield, John Howard
-
Patent number: 6632930Abstract: A method of increasing recovery of active enzyme produced in a plant is provided where the enzyme requires a transitional metal cofactor for activation. The metal cofactor is supplied to the enzyme during plant development, during extraction, or after extraction. Recovery of active enzyme is also provided by incubating the extracted enzyme at a non-enzyme degrading temperature. Addition of a negative ion salt further improves active enzyme recovery. Optimum salt concentrations for recovery of laccase from plants using copper solutions is provided.Type: GrantFiled: June 14, 2001Date of Patent: October 14, 2003Assignees: Prodigene, Inc., Genencor International Inc.Inventors: Elizabeth Hood, John A. Howard, Michele Bailey, Franciscus J. C. van Gastel, Michael Ward, Huaming Wang, Susan Woodard
-
Publication number: 20030172406Abstract: A method of improving seed set of transgenic maize plants and improving agronomic characteristics of such plants is disclosed which employs the use of maize host cells that are the result of a cross between one parent that is Stiff Stalk derived germplasm and a second parent that is from the HiII genotype.Type: ApplicationFiled: January 22, 2003Publication date: September 11, 2003Applicant: Prodigene, Inc.Inventor: Michael E. Horn
-
Publication number: 20030172409Abstract: A method of improving seed set of transgenic maize plants and improving agronomic characteristics of such plants is disclosed which employs the use of maize host cells that are the result of a cross between one parent that is Stiff Stalk derived germplasm and a second parent that is from the HiII genotype.Type: ApplicationFiled: January 22, 2003Publication date: September 11, 2003Applicant: Prodigene, Inc.Inventor: Michael E. Horn
-
Publication number: 20030066108Abstract: The invention discloses novel promoter sequences capable of expressing genes in plant cells. The promoters include engineered versions of the maize ubiquitin promoter to increase expression levels beyond those observed with the native ubiquitin promoter and alter the tissue preference. Expression constructs, vectors, transgenic plants and methods are also disclosed.Type: ApplicationFiled: February 28, 2002Publication date: April 3, 2003Applicant: ProdigeneInventors: Joseph M. Jilka, Elizabeth E. Hood, John A. Howard
-
Patent number: 6504085Abstract: A method for extraction of heterologous protein from plant seed comprises extracting the germ portion of the seed and extracting and purifying the protein from the germ. Enhanced expression in the germ is provided, and allows for improved efficiency in production, and cost savings. Directing expression to the germ portion further increases expression levels of the protein. The ubiquitin promoter preferentially directs expression to the germ portion of plant seed.Type: GrantFiled: September 7, 1999Date of Patent: January 7, 2003Assignee: ProdiGene, Inc.Inventor: John A. Howard
-
Patent number: 6136320Abstract: The anti-viral vaccine of the present invention is produced in transgenic plants and then administered through standard vaccine introduction method or through the consumption of the edible portion of those plants. A DNA sequence encoding for the expression of a surface antigen of a viral pathogen is isolated and ligated to a promoter which can regulate the production of the surface antigen in a transgenic plant. This gene is then transferred to plant cells using a procedure that results in its integration into the plant genome, such as through the use of an Agrobacterium tumenfaciens plasmid vector system. Preferably, the foreign gene is expressed in an portion of the plant that is edible by humans or animals. In a preferred procedure, the vaccine is administered through the consumption of the edible plant as food, preferably in the form of a fruit or vegetable juice which can be taken orally.Type: GrantFiled: July 7, 1998Date of Patent: October 24, 2000Assignee: Prodigene, Inc.Inventors: Charles Joel Arntzen, Dominic Man-Kit Lam
-
Patent number: 6087558Abstract: Production of proteases in plants is set forth, whereby heterologous DNA encoding the protease is introduced into the plant and expression of the protein achieved. By such methods, expression is achieved in plants wherein the plant cell is not damaged, the protein can be recovered without contamination by other proteases, and can be expressed at levels such that commercial production of the enzyme is obtained. Expression levels can be at 0.1% of total soluble protein of the plant, or higher.Type: GrantFiled: July 22, 1998Date of Patent: July 11, 2000Assignee: ProdiGene, Inc.Inventors: John A. Howard, Elizabeth Hood
-
Patent number: 6034298Abstract: The anti-viral vaccine of the present invention is produced in transgenic plants and then administered through standard vaccine introduction method or through the consumption of the edible portion of those plants. A DNA sequence encoding for the expression of a surface antigen of a viral pathogen is isolated and ligated to a promoter which can regulate the production of the surface antigen in a transgenic plant. This gene is then transferred to plant cells using a procedure that results in its integration into the plant genome, such as through the use of an Agrobacterium tumefaciens plasmid vector system. Preferably, the foreign gene is expressed in a portion of the plant that is edible by humans or animals. In a preferred procedure, the vaccine is administered through the consumption of the edible plant as food, preferably in the form of a fruit or vegetable juice which can be taken orally.Type: GrantFiled: August 23, 1996Date of Patent: March 7, 2000Assignee: Prodigene, Inc.Inventors: Dominic Man-Kit Lam, Charles Joel Arntzen, Hugh Stanley Mason